Wealthcare Advisory Partners’s ARK Genomic Revolution ETF ARKG Stock Holding History
Bought
Maintained
Sold
Other funds holding ARKG
MFPI
CIC
CFIM
BCM
PFS
PRTG
DC
PWM
LW
Wealthcare Advisory Partners's ARKG Position: Q2 2026 in Review
Wealthcare Advisory Partners increased its ARK Genomic Revolution ETF (ARKG) stake by 51% in Q2 2026, buying an estimated $280K and bringing the position to 25,946 shares worth $1.09M. The position accounts for 0.02% of the portfolio, ranked #496.
Wealthcare Advisory Partners first reported a position in ARKG in Q1 2020 and has held it in 16 quarters since. 47 funds tracked by Wall St. Rank hold ARKG as of Q2 2026.
- Wealthcare Advisory Partners held 25,946 shares of ARK Genomic Revolution ETF worth $1.09M as of Q2 2026.
- Wealthcare Advisory Partners bought 8,808 ARK Genomic Revolution ETF shares in Q2 2026, an estimated $280K.
- ARK Genomic Revolution ETF made up 0.02% of Wealthcare Advisory Partners's portfolio in Q2 2026, its #496 holding.
- Wealthcare Advisory Partners first reported a position in ARK Genomic Revolution ETF in Q1 2020 and has held it in 16 quarters since.
- 47 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2026.
Based on Wealthcare Advisory Partners's 13F filing for Q2 2026, filed 9 Jul 2026.